Human Cells Predict Danger of Lethal Drug That Animal Tests Missed

The Physicians Committee
DONATE
 
BREAKING RESEARCH NEWS July 14, 2017

Human Cells Predict Danger of Lethal Drug That Animal Tests Missed

July 14, 2017

Study in a Sentence: An international group of scientists collaborated to study why experimental drug compound BIA 10-2474 killed one previously healthy clinical trial volunteer and caused brain damage in four others, when other FAAH inhibitors have been shown to be safe, by using activity-based protein profiling (ABPP) to screen the compound using human cells and brain tissues.   

Healthy for Humans: They found that BIA 10-2474 disrupted the activity of several lipases, including an off-target enzyme that has been linked to rare neurological disorders, suggesting BIA 10-2474 may disrupt how neurons in the brain metabolize lipids.

Redefining Research: The off-target effects found using ABPP were not seen in experiments on mice, rats, monkeys, and dogs. This human-based model can be used to study on-target engagement and off-target activity in humans without sacrificing animal lives.

model of FAAH inhibitor
This image shows a model of FAAH inhibitor BIA 10-2474. Image Credit: Medical Facts

Van Esbroeck ACM, Janssen APA, Cognetta AB 3rd. Activity-based protein profiling reveals off-target protein of the FAAH inhibitor BIA 10-2474. Science. 2017;356:1084-1087. DOI: 10.1126/science.aaf7497

Subscribe to the Physicians Committee’s Breaking Research News.

Breaking Research News is a service of the Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., Ste. 400, Washington, DC 20016, 202-686-2210. Join the Physicians Committee and receive the quarterly magazine, Good Medicine.

Breaking Research News Archive:
2017 (23)
2016 (53)
2015 (53)
2014 (18)